Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma.

Agarwal S, Pappas L, Agarwal J.

Cancer Manag Res. 2017 Nov 16;9:649-656. doi: 10.2147/CMAR.S148456. eCollection 2017.

2.

Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data.

Parsons HM, Enewold LR, Banks R, Barrett MJ, Warren JL.

Med Care. 2017 Dec;55(12):e113-e119. doi: 10.1097/MLR.0000000000000462.

PMID:
29135774
3.

Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?

Wazir U, Mokbel K, Carmichael A, Mokbel K.

Cell Mol Biol Lett. 2017 Sep 4;22:20. doi: 10.1186/s11658-017-0049-x. eCollection 2017. Review.

4.

Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma.

Olszewski AJ, Dusetzina SB, Eaton CB, Davidoff AJ, Trivedi AN.

J Clin Oncol. 2017 Oct 10;35(29):3306-3314. doi: 10.1200/JCO.2017.72.2447. Epub 2017 May 25.

PMID:
28541791
5.

Physician Agency and Patient Survival.

Jacobson MG, Chang TY, Earle CC, Newhouse JP.

J Econ Behav Organ. 2017 Feb;134:27-47. doi: 10.1016/j.jebo.2016.11.011. Epub 2016 Dec 2.

6.

Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.

Thumallapally N, Meshref A, Mousa M, Terjanian T.

BMC Cancer. 2017 Jan 5;17(1):13. doi: 10.1186/s12885-016-3015-5. Erratum in: BMC Cancer. 2017 Jun 23;17 (1):443.

7.

Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).

Bradley CJ, Yabroff KR, Mariotto AB, Zeruto C, Tran Q, Warren JL.

J Clin Oncol. 2017 Feb 10;35(5):529-535. doi: 10.1200/JCO.2016.69.4166. Epub 2017 Jan 3.

8.

Does radiotherapy still have a role in unresected biliary tract cancer?

Pollom EL, Alagappan M, Park LS, Whittemore AS, Koong AC, Chang DT.

Cancer Med. 2017 Jan;6(1):129-141. doi: 10.1002/cam4.975. Epub 2016 Nov 28.

9.

The effect of statins on survival in patients with stage IV lung cancer.

Lin JJ, Ezer N, Sigel K, Mhango G, Wisnivesky JP.

Lung Cancer. 2016 Sep;99:137-42. doi: 10.1016/j.lungcan.2016.07.006. Epub 2016 Jul 6.

10.
11.

Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study.

Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, Brooks JM.

BMC Health Serv Res. 2016 Jul 18;16:274. doi: 10.1186/s12913-016-1549-5.

12.

Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.

Kale MS, Mhango G, Bonomi M, Federman A, Sigel K, Rosenzweig KE, Wisnivesky JP.

Ann Am Thorac Soc. 2016 Sep;13(9):1593-9. doi: 10.1513/AnnalsATS.201603-156OC.

13.

Lung Cancer Care Before and After Medicare Eligibility.

Huesch MD, Ong MK.

Inquiry. 2016 May 10;53. pii: 0046958016647301. doi: 10.1177/0046958016647301. Print 2016.

14.

Prostate Cancer Care Before and After Medicare Eligibility.

Huesch MD, Ong MK.

Inquiry. 2016 May 10;53. pii: 0046958016647298. doi: 10.1177/0046958016647298. Print 2016.

15.
16.

Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.

Lund JL, Sturmer T, Sanoff HK.

J Geriatr Oncol. 2016 May;7(3):176-86. doi: 10.1016/j.jgo.2016.01.011. Epub 2016 Feb 23.

17.

The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data.

Sherer EA, Fisher DA, Barnd J, Jackson GL, Provenzale D, Haggstrom DA.

BMC Health Serv Res. 2016 Feb 11;16:50. doi: 10.1186/s12913-016-1294-9.

18.

Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data.

Danese MD, Reyes CM, Gleeson ML, Halperin M, Skettino SL, Mikhael J.

Med Care. 2016 Apr;54(4):343-9. doi: 10.1097/MLR.0000000000000486.

19.

A Review of the Use of Medicare Claims Data in Plastic Surgery Outcomes Research.

Mahmoudi E, Kotsis SV, Chung KC.

Plast Reconstr Surg Glob Open. 2015 Oct 26;3(10):e530. doi: 10.1097/GOX.0000000000000497. eCollection 2015 Oct.

20.

The impact of radiotherapy costs on clinical outcomes in breast cancer.

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD.

Radiother Oncol. 2015 Nov;117(2):393-9. doi: 10.1016/j.radonc.2015.10.004. Epub 2015 Oct 20.

Supplemental Content

Support Center